<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: We investigated the contribution of cerebral nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> to neurogenic voiding dysfunction after <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>MATERIALS AND METHODS: The left mid cerebral artery in female Sprague-Dawley rats was occluded with 4-zero monofilament nylon thread </plain></SENT>
<SENT sid="2" pm="."><plain>Bladder activity was monitored during infusion cystometrography </plain></SENT>
<SENT sid="3" pm="."><plain>Time or dose dependent effects of intracerebral ventricular administration of the nonselective nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase inhibitor NG-<z:chebi fb="13" ids="29785">nitro</z:chebi>-<z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> <z:chebi fb="36" ids="29309">methyl</z:chebi> <z:chebi fb="21" ids="35701">ester</z:chebi> (L-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NAME</z:e>), were investigated in conscious, sham operated and cerebral infarcted rats </plain></SENT>
<SENT sid="4" pm="."><plain>The selective neuronal nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase inhibitor 1-(2-trifluoromethylphenyl) <z:chebi fb="0" ids="14434,16069">imidazole</z:chebi> was also administered to determine the participation of nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase subtypes </plain></SENT>
<SENT sid="5" pm="."><plain>Cross-sectional <z:mpath ids='MPATH_124'>infarct</z:mpath> area was measured and <z:mpath ids='MPATH_124'>infarct</z:mpath> volume was calculated 12 hours after mid cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Bladder capacity was reduced by 54% 30 minutes after mid cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>L-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NAME</z:e> significantly increased bladder capacity in a dose and time dependent manner in cerebral infarcted rats but had no effect on sham operated rats </plain></SENT>
<SENT sid="8" pm="."><plain>L-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NAME</z:e> (50 microg./kg.) administered 3 or 5 hours after occlusion significantly increased bladder capacity </plain></SENT>
<SENT sid="9" pm="."><plain>This effect of L-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NAME</z:e> was reversed by injecting 250 microg </plain></SENT>
<SENT sid="10" pm="."><plain><z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> per rat, which alone did not produce any significant change in bladder capacity in cerebral infarcted rats </plain></SENT>
<SENT sid="11" pm="."><plain>Administration of 1-(2-trifluoromethylphenyl) <z:chebi fb="0" ids="14434,16069">imidazole</z:chebi> also significantly increased bladder capacity in these rats </plain></SENT>
<SENT sid="12" pm="."><plain>On the other hand, 5 microg. of the <z:chebi fb="0" ids="50566">nitric oxide donor</z:chebi> FK-409 per rat reduced bladder capacity for 10 to 15 minutes </plain></SENT>
<SENT sid="13" pm="."><plain>None of the drugs affected <z:mpath ids='MPATH_124'>infarct</z:mpath> volume </plain></SENT>
<SENT sid="14" pm="."><plain>CONCLUSIONS: These results indicate that supraspinal nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> has an important role in bladder overactivity after <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> but it does not affect <z:mpath ids='MPATH_458'>normal</z:mpath> micturition in rats </plain></SENT>
<SENT sid="15" pm="."><plain>This finding suggests a central mechanism sensitive to nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> for bladder overactivity after <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> </plain></SENT>
</text></document>